Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam vs Dexmedetomidine for Cerebral Oxygen Saturation
NCT02966743Withdrawn
- Sponsor
- Gachon University Gil Medical Center
- Start
- Nov 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in Hypoxic-ischemic encephalopathy (HIE) comparing Midazolam with Dexmedetomidine (2 arms). Primary endpoint: Regional Cerebral Oxygen Saturation at 1 day. Planned start Nov 2016; status: withdrawn.
02
Drugs
midazolamdexmedetomidine
03
Conditions
Hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT02966743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02966743.